The intersection of amyloid beta and tau in glutamatergic synaptic dysfunction and collapse in Alzheimer's disease
暂无分享,去创建一个
Tara L. Spires-Jones | Jennifer I. Luebke | J. Luebke | T. Spires-Jones | M. Polydoro | J. Crimins | A. Pooler | Manuela Polydoro | Johanna L Crimins | Amy Pooler | Johanna L. Crimins
[1] J. Luebke,et al. Electrophysiological changes precede morphological changes to frontal cortical pyramidal neurons in the rTg4510 mouse model of progressive tauopathy , 2012, Acta Neuropathologica.
[2] B. Hyman,et al. Soluble forms of tau are toxic in Alzheimer’s disease , 2012, Translational neuroscience.
[3] W. Wadman,et al. Trafficking and Surface Expression of Hyperpolarization-activated Cyclic Nucleotide-gated Channels in Hippocampal Neurons* , 2010, The Journal of Biological Chemistry.
[4] B. Hyman,et al. Soluble tau Species, Not Neurofibrillary Aggregates, Disrupt Neural System Integration in a tau Transgenic Model , 2011, Journal of neuropathology and experimental neurology.
[5] D. Dickson,et al. Neurofibrillary tangle-related synaptic alterations of spinal motor neurons of P301L tau transgenic mice , 2006, Neuroscience Letters.
[6] Gábor Tamás,et al. Polarized and compartment-dependent distribution of HCN1 in pyramidal cell dendrites , 2002, Nature Neuroscience.
[7] G. Glenner,et al. Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein , 1984 .
[8] Christina M. Weaver,et al. Dendritic vulnerability in neurodegenerative disease: insights from analyses of cortical pyramidal neurons in transgenic mouse models , 2010, Brain Structure and Function.
[9] L. Buée,et al. Early axonopathy preceding neurofibrillary tangles in mutant tau transgenic mice. , 2007, The American journal of pathology.
[10] L. Mucke,et al. Amyloid-β/Fyn–Induced Synaptic, Network, and Cognitive Impairments Depend on Tau Levels in Multiple Mouse Models of Alzheimer's Disease , 2011, The Journal of Neuroscience.
[11] Shaomin Li,et al. Soluble Oligomers of Amyloid β Protein Facilitate Hippocampal Long-Term Depression by Disrupting Neuronal Glutamate Uptake , 2009, Neuron.
[12] T. Casoli,et al. Early selective vulnerability of synapses and synaptic mitochondria in the hippocampal CA1 region of the Tg2576 mouse model of Alzheimer's disease. , 2013, Journal of Alzheimer's disease : JAD.
[13] Shaomin Li,et al. Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory , 2008, Nature Medicine.
[14] Khadija Iqbal,et al. Abnormal phosphorylation of tau and the mechanism of Alzheimer neurofibrillary degeneration: sequestration of microtubule-associated proteins 1 and 2 and the disassembly of microtubules by the abnormal tau. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[15] H. Braak,et al. Alzheimer’s disease: transiently developing dendritic changes in pyramidal cells of sector CA1 of the Ammon’s horn , 1997, Acta Neuropathologica.
[16] P. Davies,et al. Age-Dependent Impairment of Cognitive and Synaptic Function in the htau Mouse Model of Tau Pathology , 2009, The Journal of Neuroscience.
[17] A. Bacci,et al. Caspase-3 triggers early synaptic dysfunction in a mouse model of Alzheimer's disease , 2011, Nature Neuroscience.
[18] S. DeKosky,et al. Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity , 1990, Annals of neurology.
[19] M. Goedert,et al. A Century of Alzheimer's Disease , 2006, Science.
[20] C. Masters,et al. Amyloid plaque core protein in Alzheimer disease and Down syndrome. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[21] D. Salmon,et al. Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment , 1991, Annals of neurology.
[22] E. Mandelkow,et al. Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress , 2002, The Journal of cell biology.
[23] D. Dickson,et al. Ultrastructural neuronal pathology in transgenic mice expressing mutant (P301L) human tau , 2003, Journal of neurocytology.
[24] J. Bourne,et al. Balancing structure and function at hippocampal dendritic spines. , 2008, Annual review of neuroscience.
[25] Virginia M. Y. Lee,et al. Staging of neurofibrillary degeneration caused by human tau overexpression in a unique cellular model of human tauopathy. , 2001, The American journal of pathology.
[26] D. Selkoe,et al. Soluble amyloid β-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration , 2011, Proceedings of the National Academy of Sciences.
[27] R. Tanzi,et al. Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses , 2008, Nature Reviews Neuroscience.
[28] E. Mandelkow,et al. Linking Amyloid-β and Tau: Amyloid-β Induced Synaptic Dysfunction via Local Wreckage of the Neuronal Cytoskeleton , 2011, Neurodegenerative Diseases.
[29] Brian J. Bacskai,et al. Aβ Plaques Lead to Aberrant Regulation of Calcium Homeostasis In Vivo Resulting in Structural and Functional Disruption of Neuronal Networks , 2008, Neuron.
[30] K. Grzeschik,et al. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor , 1987, Nature.
[31] Bin Zhang,et al. Age-Dependent Emergence and Progression of a Tauopathy in Transgenic Mice Overexpressing the Shortest Human Tau Isoform , 1999, Neuron.
[32] Ezzie Hutchinson,et al. Systems neuroscience: The stress of dieting , 2011, Nature Reviews Neuroscience.
[33] A. Peters,et al. Homeostatic responses by surviving cortical pyramidal cells in neurodegenerative tauopathy , 2011, Acta Neuropathologica.
[34] B. Hyman,et al. The synaptic accumulation of hyperphosphorylated tau oligomers in Alzheimer disease is associated with dysfunction of the ubiquitin-proteasome system. , 2012, The American journal of pathology.
[35] Sangmook Lee,et al. Accumulation of Vesicle-Associated Human Tau in Distal Dendrites Drives Degeneration and Tau Secretion in an In Situ Cellular Tauopathy Model , 2012, International journal of Alzheimer's disease.
[36] U. Sengupta,et al. Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice , 2011, Molecular Neurodegeneration.
[37] L. Mucke,et al. Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model , 2007, Science.
[38] Ger J. A. Ramakers,et al. Improved Long-Term Potentiation and Memory in Young Tau-P301L Transgenic Mice before Onset of Hyperphosphorylation and Tauopathy , 2006, The Journal of Neuroscience.
[39] P. T. Nguyen,et al. Dendritic Spine Abnormalities in Amyloid Precursor Protein Transgenic Mice Demonstrated by Gene Transfer and Intravital Multiphoton Microscopy , 2005, The Journal of Neuroscience.
[40] Bin Zhang,et al. Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model , 2007, Neuron.
[41] P. Livrea,et al. Soluble β-Amyloid1-40 Induces NMDA-Dependent Degradation of Postsynaptic Density-95 at Glutamatergic Synapses , 2005, The Journal of Neuroscience.
[42] J. Götz,et al. Phosphorylated Tau Interacts with c-Jun N-terminal Kinase-interacting Protein 1 (JIP1) in Alzheimer Disease* , 2009, The Journal of Biological Chemistry.
[43] D. Selkoe,et al. Natural oligomers of the amyloid-β protein specifically disrupt cognitive function , 2005, Nature Neuroscience.
[44] M. Albert,et al. Early Aβ accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain , 2004, Neurology.
[45] J. Luebke,et al. Structural and functional changes in tau mutant mice neurons are not linked to the presence of NFTs , 2010, Experimental Neurology.
[46] O. Vitolo,et al. Dendrite and dendritic spine alterations in alzheimer models , 2004, Journal of neurocytology.
[47] P. Caroni,et al. Structural plasticity upon learning: regulation and functions , 2012, Nature Reviews Neuroscience.
[48] L. Buée,et al. P1–062: Alzheimer's disease–like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits , 2006, The American journal of pathology.
[49] B. Hyman,et al. Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function , 2005, Science.
[50] E. Mandelkow,et al. Aβ Oligomers Cause Localized Ca2+ Elevation, Missorting of Endogenous Tau into Dendrites, Tau Phosphorylation, and Destruction of Microtubules and Spines , 2010, The Journal of Neuroscience.
[51] B. Hyman,et al. Synaptic alterations in the rTg4510 mouse model of tauopathy , 2013, The Journal of comparative neurology.
[52] T. Morgan,et al. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[53] C. Finch,et al. Synaptic Targeting by Alzheimer's-Related Amyloid β Oligomers , 2004, The Journal of Neuroscience.
[54] D. Selkoe. Alzheimer's Disease Is a Synaptic Failure , 2002, Science.
[55] D. Selkoe,et al. Soluble oligomers of the amyloid β-protein impair synaptic plasticity and behavior , 2008, Behavioural Brain Research.
[56] Bernardo L Sabatini,et al. Synapses and Alzheimer's disease. , 2012, Cold Spring Harbor perspectives in biology.
[57] Stephen J. Smith,et al. Single-Synapse Analysis of a Diverse Synapse Population: Proteomic Imaging Methods and Markers , 2010, Neuron.
[58] Jaime Grutzendler,et al. Fibrillar amyloid deposition leads to local synaptic abnormalities and breakage of neuronal branches , 2004, Nature Neuroscience.
[59] B. Hyman,et al. Alzheimer's disease: synapses gone cold , 2011, Molecular Neurodegeneration.
[60] W. Thies,et al. 2013 Alzheimer's disease facts and figures , 2013, Alzheimer's & Dementia.
[61] Brett Chromy,et al. Soluble oligomers of β amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus , 2002, Brain Research.
[62] H. Geerts,et al. Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein. , 1999, The American journal of pathology.
[63] A. Peters,et al. Tau accumulation causes mitochondrial distribution deficits in neurons in a mouse model of tauopathy and in human Alzheimer's disease brain. , 2011, The American journal of pathology.
[64] R. A. Crowther,et al. Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein , 2000, Acta Neuropathologica.
[65] J. Magee. Dendritic Hyperpolarization-Activated Currents Modify the Integrative Properties of Hippocampal CA1 Pyramidal Neurons , 1998, The Journal of Neuroscience.
[66] Tara Spires-Jones,et al. Spines, Plasticity, and Cognition in Alzheimer's Model Mice , 2011, Neural plasticity.
[67] J. Trojanowski,et al. Tau-mediated neurodegeneration in Alzheimer's disease and related disorders , 2007, Nature Reviews Neuroscience.
[68] Jürgen Götz,et al. Amyloid-β and tau — a toxic pas de deux in Alzheimer's disease , 2011, Nature Reviews Neuroscience.
[69] S. Kügler,et al. Dendritic degeneration, neurovascular defects, and inflammation precede neuronal loss in a mouse model for tau-mediated neurodegeneration. , 2011, The American journal of pathology.
[70] B. Hyman,et al. Calcineurin inhibition with FK506 ameliorates dendritic spine density deficits in plaque-bearing Alzheimer model mice , 2011, Neurobiology of Disease.
[71] Bernardo L Sabatini,et al. Natural Oligomers of the Alzheimer Amyloid-β Protein Induce Reversible Synapse Loss by Modulating an NMDA-Type Glutamate Receptor-Dependent Signaling Pathway , 2007, The Journal of Neuroscience.
[72] W. K. Cullen,et al. Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo , 2002, Nature.
[73] Jürgen Götz,et al. Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models , 2010, Cell.
[74] From Mitochondrial Dysfunction to Amyloid Beta Formation: Novel Insights into the Pathogenesis of Alzheimer’s Disease , 2012, Molecular Neurobiology.
[75] K. Ashe,et al. Tau Mislocalization to Dendritic Spines Mediates Synaptic Dysfunction Independently of Neurodegeneration , 2010, Neuron.
[76] B. Strooper,et al. The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics , 2011, Nature Reviews Drug Discovery.
[77] I. Grundke‐Iqbal,et al. Cytosolic abnormally hyperphosphorylated tau but not paired helical filaments sequester normal MAPs and inhibit microtubule assembly. , 2008, Journal of Alzheimer's disease : JAD.
[78] Kristina D. Micheva,et al. Oligomeric amyloid β associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques , 2009, Proceedings of the National Academy of Sciences.
[79] Thomas Arendt,et al. Synaptic degeneration in Alzheimer’s disease , 2009, Acta Neuropathologica.
[80] Tara Spires-Jones,et al. Amyloid β Induces the Morphological Neurodegenerative Triad of Spine Loss, Dendritic Simplification, and Neuritic Dystrophies through Calcineurin Activation , 2010, The Journal of Neuroscience.
[81] Shaomin Li,et al. Soluble Aβ Oligomers Inhibit Long-Term Potentiation through a Mechanism Involving Excessive Activation of Extrasynaptic NR2B-Containing NMDA Receptors , 2011, The Journal of Neuroscience.
[82] R. Malinow,et al. AMPAR Removal Underlies Aβ-Induced Synaptic Depression and Dendritic Spine Loss , 2006, Neuron.
[83] S. Lipton,et al. S-Nitrosylation activates Cdk5 and contributes to synaptic spine loss induced by β-amyloid peptide , 2011, Proceedings of the National Academy of Sciences.
[84] Steven Hou,et al. Apolipoprotein E4 effects in Alzheimer's disease are mediated by synaptotoxic oligomeric amyloid-β. , 2012, Brain : a journal of neurology.
[85] Ram Dixit,et al. Differential Regulation of Dynein and Kinesin Motor Proteins by Tau , 2008, Science.
[86] T. Shea,et al. Tau inhibits anterograde axonal transport and perturbs stability in growing axonal neurites in part by displacing kinesin cargo: neurofilaments attenuate tau-mediated neurite instability. , 2008, Cell motility and the cytoskeleton.
[87] E. Mandelkow,et al. Missorting of Tau in Neurons Causes Degeneration of Synapses That Can Be Rescued by the Kinase MARK2/Par-1 , 2007, The Journal of Neuroscience.
[88] A. Alzheimer. Uber eine eigenartige Erkrankung der Hirnrinde , 1907 .
[89] Rudi D'Hooge,et al. Tau-Induced Defects in Synaptic Plasticity, Learning, and Memory Are Reversible in Transgenic Mice after Switching Off the Toxic Tau Mutant , 2011, The Journal of Neuroscience.
[90] P. Greengard,et al. Regulation of NMDA receptor trafficking by amyloid-β , 2005, Nature Neuroscience.
[91] B. Hyman,et al. Neuropathology of Alzheimer's disease. , 2008, Handbook of clinical neurology.
[92] D. Selkoe. Alzheimer's disease: genes, proteins, and therapy. , 2001, Physiological reviews.
[93] Kristina D. Micheva,et al. Array Tomography: A New Tool for Imaging the Molecular Architecture and Ultrastructure of Neural Circuits , 2007, Neuron.
[94] K. Kosik,et al. Microtubular reorganization and dendritic growth response in alzheimer's disease , 1989, Annals of neurology.
[95] P. Coleman,et al. Synaptic slaughter in Alzheimer’s disease , 2003, Neurobiology of Aging.
[96] Hermann Bujard,et al. The β-Propensity of Tau Determines Aggregation and Synaptic Loss in Inducible Mouse Models of Tauopathy* , 2007, Journal of Biological Chemistry.
[97] T. Lanz,et al. Dendritic spine loss in the hippocampus of young PDAPP and Tg2576 mice and its prevention by the ApoE2 genotype , 2003, Neurobiology of Disease.
[98] Alan Peters,et al. Structural abnormalities in the cortex of the rTg4510 mouse model of tauopathy: a light and electron microscopy study , 2011, Brain Structure and Function.